Health Catalyst Inc. | Small-cap | Healthcare
$3.39
-7.12%
| Health Catalyst Stock Comparison:
Health Catalyst vs Veeva SystemsHealth Catalyst vs Ge HealthcareHealth Catalyst vs Sophia Genetics SAHealth Catalyst vs PerformantHealth Catalyst vs CareCloudHealth Catalyst vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 79.4M
Gross Profit 36.2M 45.63%
Operating Income -20.2M -25.40%
Net Income -23.7M -29.90%
EPS (Diluted) $-0.35

Balance Sheet Metrics

Total Assets 891.5M
Total Liabilities 514.7M
Shareholders Equity 376.8M
Debt to Equity 1.37

Cash Flow Metrics

Operating Cash Flow -380.0K
Free Cash Flow -5.1M

Revenue & Profitability Trend

Health Catalyst Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i306.6M295.9M276.2M241.9M188.8M
Cost of Goods Sold i165.8M164.1M143.0M124.4M98.1M
Gross Profit i140.8M131.8M133.2M117.6M90.8M
Gross Margin % i45.9%44.5%48.2%48.6%48.1%
Operating Expenses
Research & Development i58.0M72.6M75.7M62.7M53.5M
Selling, General & Administrative i111.2M143.9M149.2M161.0M114.7M
Other Operating Expenses i-----
Total Operating Expenses i169.2M216.5M224.9M223.7M168.2M
Operating Income i-69.8M-126.9M-140.0M-143.6M-96.1M
Operating Margin % i-22.8%-42.9%-50.7%-59.4%-50.9%
Non-Operating Items
Interest Income i18.0M16.4M5.7M831.0K2.1M
Interest Expense i17.1M7.3M7.2M17.3M11.6M
Other Non-Operating Income-259.0K4.0K-126.0K24.0K-8.5M
Pre-tax Income i-69.2M-117.8M-141.7M-160.1M-116.2M
Income Tax i333.0K356.0K-4.3M-6.9M-1.2M
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-69.5M-118.1M-137.4M-153.2M-115.0M
Net Margin % i-22.7%-39.9%-49.7%-63.3%-60.9%
Key Metrics
EBITDA i-10.7M-68.3M-86.1M-106.1M-77.4M
EPS (Basic) i$-1.15$-2.09$-2.56$-3.23$-2.91
EPS (Diluted) i$-1.15$-2.09$-2.63$-3.23$-2.91
Basic Shares Outstanding i6018500056418000537220004749500039541000
Diluted Shares Outstanding i6018500056418000537220004749500039541000

Income Statement Trend

Health Catalyst Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i249.6M106.3M116.3M193.2M92.0M
Short-term Investments i142.4M211.5M247.2M251.8M178.9M
Accounts Receivable i57.2M60.3M48.0M48.8M48.3M
Inventory i-----
Other Current Assets16.5M15.4M16.3M14.6M-
Total Current Assets i465.6M393.4M427.8M508.4M329.8M
Non-Current Assets
Property, Plant & Equipment i12.1M13.9M16.7M21.1M24.8M
Goodwill i605.6M454.7M464.2M444.7M314.6M
Intangible Assets i86.1M73.4M92.2M104.8M98.9M
Long-term Investments-----
Other Non-Current Assets6.0M4.7M3.7M4.5M3.6M
Total Non-Current Assets i393.3M308.4M324.5M323.7M247.9M
Total Assets i858.9M701.8M752.3M832.1M577.7M
Liabilities
Current Liabilities
Accounts Payable i11.4M6.6M4.4M4.7M5.3M
Short-term Debt i234.8M3.4M3.4M3.4M2.6M
Current Portion of Long-term Debt-----
Other Current Liabilities---4.6M14.4M
Total Current Liabilities i325.8M89.0M82.5M93.1M88.0M
Non-Current Liabilities
Long-term Debt i167.5M245.7M244.5M201.2M192.7M
Deferred Tax Liabilities i-----
Other Non-Current Liabilities154.0K74.0K121.0K14.8M19.1M
Total Non-Current Liabilities i167.9M245.9M244.8M216.9M213.6M
Total Liabilities i493.7M334.9M327.3M310.0M301.6M
Equity
Common Stock i1.6B1.5B1.4B1.4B43.0K
Retained Earnings i-1.2B-1.1B-999.0M-878.9M-725.6M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i365.2M366.9M425.0M522.1M276.1M
Key Metrics
Total Debt i402.3M249.1M248.0M204.6M195.3M
Working Capital i139.8M304.4M345.3M415.3M241.8M

Balance Sheet Composition

Health Catalyst Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-69.5M-118.1M-137.4M-153.2M-115.0M
Depreciation & Amortization i41.4M42.2M48.3M37.5M18.7M
Stock-Based Compensation i40.1M55.8M72.1M65.1M38.0M
Working Capital Changes i-610.0K-13.8M-13.4M9.1M-160.0K
Operating Cash Flow i16.0M-29.4M-38.3M-22.2M-33.2M
Investing Activities
Capital Expenditures i-1.6M-1.2M-2.1M-10.4M-7.8M
Acquisitions i-80.3M-11.4M-27.8M-46.8M-101.7M
Investment Purchases i-168.3M-290.8M-309.0M-261.4M-189.5M
Investment Sales i242.1M336.8M315.2M186.9M219.1M
Investing Cash Flow i-8.1M33.4M-23.8M-131.7M-79.9M
Financing Activities
Share Repurchases i0-1.8M-8.4M00
Dividends Paid i-----
Debt Issuance i152.3M-00222.5M
Debt Repayment i-959.0K-00-57.0M
Financing Cash Flow i149.2M-1.8M-9.7M238.9M85.0M
Free Cash Flow i-1.8M-47.4M-52.7M-41.6M-36.6M
Net Change in Cash i157.0M2.1M-71.8M85.0M-28.1M

Cash Flow Trend

Health Catalyst Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -2.96
Forward P/E 8.07
Price to Book 0.69
Price to Sales 0.75
PEG Ratio -0.02

Profitability Ratios

Profit Margin -31.67%
Operating Margin -14.45%
Return on Equity -28.42%
Return on Assets -4.99%

Financial Health

Current Ratio 1.83
Debt to Equity 49.72
Beta 1.46

Per Share Data

EPS (TTM) $-1.51
Book Value per Share $4.95
Revenue per Share $4.84

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
hcat323.0M-2.960.69-28.42%-31.67%49.72
Veeva Systems 35.5B55.286.6313.70%27.29%1.29
Ge Healthcare 39.5B15.113.4725.80%11.22%107.67
Sophia Genetics SA 237.2M-3.643.05-74.09%-105.32%83.21
Performant 218.4M-58.697.33-1.12%-0.64%11.04
CareCloud 49.7M-13.142.7822.69%10.08%6.04

Financial data is updated regularly. All figures are in the company's reporting currency.